Target intelligence / Profile preview

NFYB pseudogene 1 (NFYBP1)

Target
NFYBP1
Molecular classification
Other (pseudogene)
01

Overview

NFYB pseudogene 1 (NFYBP1) is a genomic region in humans labeled as a **pseudogene** of the NFYB gene, which encodes the Nuclear transcription factor Y subunit beta. Pseudogenes are DNA sequences related to functional genes that have lost their protein-coding ability due to mutations or truncations[4][7]. NFYBP1 does not code for a functional receptor, enzyme, or protein, and is not considered an actionable molecular target in biomedical research or drug development. While some pseudogenes can exert regulatory functions at the RNA level—such as serving as antisense transcripts, small interfering RNAs (siRNAs), or competing endogenous RNAs (ceRNAs)—there is no specific evidence that NFYBP1 possesses such properties. Most experimental and clinical information relates to the actual NFYB gene, a subunit of a transcription factor involved in gene regulation and implicated in some disease contexts, not its pseudogene[1][2][3]. **Summary:** NFYB pseudogene 1 is a non-functional genomic sequence, not considered a therapeutic target; most molecular, pharmaceutical, or disease-related relevance pertains only to its parent gene, nuclear transcription factor Y subunit beta (NFYB), not to this pseudogene.

Other names
NFYBP1nuclear transcription factor Y subunit beta pseudogene 1
02

Biological functions

Other (no specific biological function; pseudogenes generally do not encode functional proteins, but may occasionally have regulatory RNA roles)
03

Disease associations

Other (no direct evidence of involvement in disease; most studies focus on the parent functional gene, NFYB)

Beyond the preview

Go deeper on NFYB pseudogene 1 (NFYBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFYB pseudogene 1 (NFYBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call